CIK 0000872589
- Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- Operating
- EIN
- 133444607
- Phone
- +1 914-847-7000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- 4 Shares withheld for taxes EVP Research gave up 492 shares (to pay taxes)
- 4 Shares withheld for taxes EVP Commercial gave up 274 shares (to pay taxes)
- 4 Shares withheld for taxes EVP General Counsel and Secret gave up 492 shares (to pay taxes)
- 4 Gift EVP Research gave 1,185 shares (gift)
- 4 Planned sale EVP Commercial sold 1,000 shares at $844.61 ($844,610)
- 4 Planned sale Director sold 100 shares at an average $1,048.78 ($104,878)
- 4 Planned sale EVP Commercial sold 1,000 shares at $1,054.06 ($1,054,060)
- 4 Gift Director gave 1,200 shares (gift)
- 4 Planned sale EVP Commercial sold 1,000 shares at $1,178.73 ($1,178,730)
- 4 Planned sale Director sold 100 shares at an average $1,178.69 ($117,869)
- 4 Open-market sale SVP Finance & CFO sold 5,680 shares at an average $1,205.33 ($6,846,262)
- 4 Planned sale Director sold 756 shares at $1,170.00 ($884,520)
- 4 Open-market sale Director sold 10,838 shares at an average $1,158.17 ($12,552,285)
- 4 Planned sale EVP Research sold 6,363 shares at an average $1,153.15 ($7,337,505)
- 4 Gift EVP Research and Development gave 500 shares (gift)
- 4 Planned sale EVP Research and Development sold 5,197 shares at an average $1,084.54 ($5,636,346)
- 4 Open-market sale VP Controller sold 487 shares at $1,070.00 ($521,090)
- 4 Shares withheld for taxes EVP Research and Development gave up 18,441 shares (to pay taxes)
- 4 Planned sale Director sold 756 shares at $1,115.00 ($842,940)
- 4 Planned sale EVP Commercial sold 1,137 shares at $1,060.86 ($1,206,198)
Page 5 of 77 · 1,533 filings